These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 16444920

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Recent advances in the pathogenesis and immunotherapy of multiple sclerosis].
    Gold R, Rieckmann P.
    Nervenarzt; 2007 Sep; 78 Suppl 1():15-24; quiz 25. PubMed ID: 17668159
    [Abstract] [Full Text] [Related]

  • 3. [Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)].
    Multiple Sklerose Therapie Konsensus Gruppe (MSTKG), Rieckmann P.
    Nervenarzt; 2006 Dec; 77(12):1506-18. PubMed ID: 17136556
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Choice of early and escalation treatment options for multiple sclerosis].
    Linker RA, Kieseier BC.
    Nervenarzt; 2008 Oct; 79(10):1123-4,1126-8,1130-2 passim. PubMed ID: 18806985
    [Abstract] [Full Text] [Related]

  • 7. Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.
    Pula JH, Javed A.
    Curr Opin Ophthalmol; 2009 Nov; 20(6):476-81. PubMed ID: 19816177
    [Abstract] [Full Text] [Related]

  • 8. Key issues in the diagnosis and treatment of multiple sclerosis. An overview.
    O'Connor P, Canadian Multiple Sclerosis Working Group.
    Neurology; 2002 Sep 24; 59(6 Suppl 3):S1-33. PubMed ID: 12448786
    [No Abstract] [Full Text] [Related]

  • 9. [Diagnosis and therapy in multiple sclerosis].
    Sailer M.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 May 24; 45(5):328-34. PubMed ID: 20455189
    [Abstract] [Full Text] [Related]

  • 10. Treatment of multiple sclerosis and related disorders: what's new in the past 2 years?
    Noseworthy JH.
    Clin Neuropharmacol; 2003 May 24; 26(1):28-37. PubMed ID: 12567162
    [No Abstract] [Full Text] [Related]

  • 11. Natalizumab for relapsing remitting multiple sclerosis.
    Pucci E, Giuliani G, Solari A, Simi S, Minozzi S, Di Pietrantonj C, Galea I.
    Cochrane Database Syst Rev; 2011 Oct 05; (10):CD007621. PubMed ID: 21975773
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. What is new in the treatment of multiple sclerosis?
    Weinstock-Guttman B, Jacobs LD.
    Drugs; 2000 Mar 05; 59(3):401-10. PubMed ID: 10776827
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Functional improvement and symptom management in multiple sclerosis: clinical efficacy of current therapies.
    Berger JR.
    Am J Manag Care; 2011 May 05; 17 Suppl 5 Improving():S146-53. PubMed ID: 21761953
    [Abstract] [Full Text] [Related]

  • 18. Recent developments in multiple sclerosis therapeutics.
    Spain RI, Cameron MH, Bourdette D.
    BMC Med; 2009 Dec 07; 7():74. PubMed ID: 19968863
    [Abstract] [Full Text] [Related]

  • 19. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC, Hartung HP.
    Semin Neurol; 2003 Jun 07; 23(2):133-46. PubMed ID: 12894379
    [Abstract] [Full Text] [Related]

  • 20. New and emerging treatment options for multiple sclerosis.
    Polman CH, Uitdehaag BM.
    Lancet Neurol; 2003 Sep 07; 2(9):563-6. PubMed ID: 12941579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.